Opinion

Video

Role of Ruxolitinib in Steroid-Refractory Chronic GvHD

Dr. Chaudhary introduces data supporting the use of ruxolitinib as a first-line option in patients with steroid-refractory chronic GvHD.

Video Player is loading.
Current Time 0:00
Duration 4:10
Loaded: 0%
Stream Type LIVE
Remaining Time 4:10
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected
Related Content